
Glitip P 2mg/500mg/15mg Tablet SR
Marketer
Iva Healthcare Pvt. Ltd.
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glitip P 2mg/500mg/15mg Tablet SR
Combiplus DM 2mg/500mg/15mg Extended-Release Tablets are a multi-component medication designed to manage elevated blood glucose. This medication, used in conjunction with a healthy diet and regular physical activity, enhances glycemic control in adult patients with type 2 diabetes. It facilitates improved insulin utilization, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and regimen for Combiplus DM. Administering the medication with food minimizes gastrointestinal discomfort. Should you miss a dose, take it promptly; however, if your next dose is imminent, omit the missed dose and resume your regular schedule. Never double the dose. An overdose can trigger hypoglycemia (low blood sugar). Concomitant use with other antidiabetic agents, alcohol consumption, or skipped meals increases the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Common adverse events may encompass nausea, diarrhea, abdominal pain, cephalalgia, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing renal, hepatic, or cardiac conditions to your healthcare provider. Pregnant or lactating women should seek medical counsel before initiating therapy. Kidney function assessment will be conducted by your physician before treatment commences. Limit alcohol consumption while using this medication to mitigate potential side effects.
Primary Ingredients of Glitip P 2mg/500mg/15mg Tablet SR
No information provided. Unable to rephrase.
Uses of Glitip P 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glitip P 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glitip P 2mg/500mg/15mg SR tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Glitip P 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glitip P 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glitip P 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. This medication should be administered with food.
How Glitip P 2mg/500mg/15mg Tablet SR works:
Glitip P SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions. This triple combination improves blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption and Glitip P 2mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glitip P 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glitip P 2mg/500mg/15mg tablet is likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Glitip P 2mg/500mg/15mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. For patients exhibiting severe kidney disease, the use of Glitip P 2mg/500mg/15mg SR tablets is contraindicated. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glitip P 2mg/500mg/15mg SR tablets cautiously, as dose modification may be necessary. Consult a physician for guidance. Glitip P 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glitip P 2mg/500mg/15mg Tablet SR :
Should you forget to take your Glitip P 2mg/500mg/15mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glitip P 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
